Drug intelligence / Profile preview

Soothe XP

Development stage: Unknown
Lead developer: Bausch + Lomb
Administration: Ophthalmic

Overview

**Soothe XP** is a Bausch + Lomb over-the-counter ophthalmic emollient lubricant product for temporary relief of burning, irritation, and dryness of the eye. Its active ingredients are light mineral oil 1.0% and mineral oil 4.5%. The mineral-oil formulation supplements the tear-film lipid layer, helping seal in moisture, reduce evaporative tear loss, and protect the ocular surface from further irritation. Clinical evidence in patients with meibomian gland dysfunction and lipid-deficient dry eye found that a single dose significantly increased tear-film lipid-layer thickness at 15 minutes. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0f053da-8d22-433e-a36e-79cf15ad387f))

Brand names: Soothe XP
Other names: Soothe XP Xtra ProtectionSoothe XP Emollient Lubricant Eye Drops

Beyond the preview

Go deeper on Soothe XP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soothe XP.

Explore the full profile